Suleyman Gulsuner

Suleyman Gulsuner

Auto-generated profile, based on publicly available information

Suleyman Gulsuner

Department of Medicine, University of Washington

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 January 2020 in Science
Verified
Journal Article
Closed access
PDF file
SGS. Gulsuner
S. Gulsuner
DSD. J. Stein
D. J. Stein
ESE. S. Susser
E. S. Susser
GSG. Sibeko
G. Sibeko
APA. Pretorius
A. Pretorius
JMJ. M. McClellan
J. M. McClellan
African schizophrenia genetic variants: The genetics of schizophrenia have predominately been studied in populations of European and Asian descent. However, studies in Africans, who host the greatest degree of human genetic diversity, have lagged. Examining the exomes of more than 1800 Xhosa individuals from South Africa, about half of which have been diagnosed with schizophrenia, Gulsuner et al. identified both rare and common genetic variants associated with the disease. They found that the genetic architecture of schizophrenia in Africans generally reflects that of Europeans but that the greater genetic variation in Africa provides more power to detect relationships of genes to phenotypes. Science , this issue p. 569

28 January 2021 in Leukemia
Verified
Journal Article
Closed access
PDF file
SFSimone Feurstein
Simone Feurstein
JCJane E. Churpek
Jane E. Churpek
TWTom Walsh
Tom Walsh
SKSioban Keel
Sioban Keel
MHMarja Hakkarainen
Marja Hakkarainen
LGLucy Godley
Lucy Godley

3 August 2020 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
ARAmal Abu Rayyan
Amal Abu Rayyan
LKLara Kamal
Lara Kamal
SCSilvia Casadei
Silvia Casadei
ZBZippora Brownstein
Zippora Brownstein
FZFouad Zahdeh
Fouad Zahdeh
MKMoien N. Kanaan
Moien N. Kanaan
Significance: The genetic characterization of a common phenotype for an entire population reveals both the genetic epidemiology of that phenotype and the power of family-based, population-wide genomic analysis. We characterized the genetics of hearing loss throughout the Palestinian population of the West Bank and Gaza. In families with no prior history of hearing loss, we estimate that 56% of hearing loss is genetic and 44% is not genetic. For most families with inherited hearing loss, causal genes and mutations were identified. Most inherited hearing loss in the population was attributable to consanguinity. Given the ongoing decline in consanguineous marriage, inherited hearing loss will likely be much rarer in the next generation.

30 January 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
HHHolger Hengel
Holger Hengel
CBCélia Bosso-Lefèvre
Célia Bosso-Lefèvre
GGGeorge Grady
George Grady
ESEmmanuelle Szenker-Ravi
Emmanuelle Szenker-Ravi
HLHankun Li
Hankun Li
BRBruno Reversade
Bruno Reversade
Developmental epileptic encephalopathies are devastating disorders characterized by intractable epileptic seizures and developmental delay. Here, we report an allelic series of germline recessive mutations in UGDH in 36 cases from 25 families presenting with epileptic encephalopathy with developmental delay and hypotonia. UGDH encodes an oxidoreductase that converts UDP-glucose to UDP-glucuronic acid, a key component of specific proteoglycans and glycolipids. Consistent with being loss-of-function alleles, we show using patients’ primary fibroblasts and biochemical assays, that these mutations either impair UGDH stability, oligomerization, or enzymatic activity. In vitro, patient-derived cerebral organoids are smaller with a reduced number of proliferating neuronal progenitors while mutant ugdh zebrafish do not phenocopy the human disease. Our study defines UGDH as a key player for the production of extracellular matrix components that are essential for human brain development. Based on the incidence of variants observed, UGDH mutations are likely to be a frequent cause of recessive epileptic encephalopathy.

15 October 2020 in Journal of Medical Genetics
Verified
Journal Article
Open access
PDF file
TWTomas Walsh
Tomas Walsh
SCSilvia Casadei
Silvia Casadei
KMKatherine M Munson
Katherine M Munson
MEMary Eng
Mary Eng
JMJessica B Mandell
Jessica B Mandell
MKMary-Claire King
Mary-Claire King
Current clinical approaches for mutation discovery are based on short sequence reads (100–300 bp) of exons and flanking splice sites targeted by multigene panels or whole exomes. Short-read sequencing is highly accurate for detection of single nucleotide variants, small indels and simple copy number differences but is of limited use for identifying complex insertions and deletions and other structural rearrangements. We used CRISPR-Cas9 to excise complete BRCA1 and BRCA2 genomic regions from lymphoblast cells of patients with breast cancer, then sequenced these regions with long reads (>10 000 bp) to fully characterise all non-coding regions for structural variation. In a family severely affected with early-onset bilateral breast cancer and with negative (normal) results by gene panel and exome sequencing, we identified an intronic SINE-VNTR-Alu retrotransposon insertion that led to the creation of a pseudoexon in the BRCA1 message and introduced a premature truncation. This combination of CRISPR–Cas9 excision and long-read sequencing reveals a class of complex, damaging and otherwise cryptic mutations that may be particularly frequent in tumour suppressor genes replete with intronic repeats.

20 July 2020 in Clinical Genetics
Verified
Journal Article
Closed access
PDF file
ZBZippora Brownstein
Zippora Brownstein
SGSuleyman Gulsuner
Suleyman Gulsuner
TWTomas Walsh
Tomas Walsh
FMFábio T.A. Martins
Fábio T.A. Martins
STShahar Taiber
Shahar Taiber
KAKaren B. Avraham
Karen B. Avraham